Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

Background Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of
life and school and work performance and is a frequent reason for office visits in general …

Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence-…

Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, …

Background: Venous thromboembolism (VTE) is the third most common vascular disease.
Medical inpatients, long-term care residents, persons with minor injuries, and long-distance …

Background: Although several tools to evaluate the credibility of health care guidelines exist,
guidance on practical steps for developing guidelines is lacking. We systematically …

Systematic reviews are difficult to keep up to date, but failure to do so leads to a decay in
review currency, accuracy, and utility. We are developing a novel approach to systematic …

Background Guideline developers can: (1) adopt existing recommendations from others; (2)
adapt existing recommendations to their own context; or (3) create recommendations de …

Background: Venous thromboembolism (VTE) is a common source of perioperative morbidity
and mortality. Objective: These evidence-based guidelines from the American Society of …

Background: COVID-19–related acute illness is associated with an increased risk of venous
thromboembolism (VTE). Objective: These evidence-based guidelines from the American …